Erenzo contains roxadustat, a first-in-class, orally administered HIF-PH inhibitor. It promotes erythropoiesis by:
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
General Guidelines:
Initial Dosing:
Patients not on EPO-stimulating agents:
Patients switching from EPO-stimulating agents:
Dose Adjustments:
- Children: Not indicated.
- Severe liver dysfunction: Not recommended.
Missed Dose:
Administration:
Symptoms: Elevated heart rate and Hb concentration.
Management: Reduce or discontinue dose as necessary. Roxadustat is not removed by dialysis.
With phosphate binders and multivalent cation products (except lanthanum carbonate):
With gemfibrozil or probenecid:
With OATP1B1 or BCRP substrates (e.g., simvastatin, rosuvastatin, atorvastatin):
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.